Skip to main content
Not Found
Digital Seminar

Respiratory Medication Updates for Advanced Practice Clinicians: Proven Strategies for Prescription Success

Paul Langlois, APN, PhD, CCRN, CCNS
6 Hours 25 Minutes
Audio and Video
Sep 13, 2021
Product Code:
Media Type:
Digital Seminar


Nurse practitioners, physician assistants and physicians have confided in me that they felt apprehension ordering respiratory medications due to an inability to stay current on pharmacology best practices and the complexity required to manage multiple conditions or symptoms at once. It can feel overwhelming. I certainly understand that we want to help our patients achieve their best outcomes. We also certainly don’t want to contribute to dire patient consequences.

I have been able to assist countless healthcare providers to overcome their prescriptive and administration fears. One particular nurse stands out in my memory. She was scared. And absolutely refused to give a prescribed medication to a patient on our unit. We went together, and both delivered the medication that the patient needed. After a “thank you” and many years later, she became a highly respected nurse practitioner with the Pulmonary Division of our institution. She never gave up and kept asking questions. She wanted to learn, and that curiosity to learn propelled her to high achievement in her specialty.

As we walk together through this essential content, I will present real world case studies to reinforce key points, whether you work in an inpatient or outpatient setting. I will talk through assessment findings and laboratory results to guide expert level pharmacology decisions. You will conclude this comprehensive respiratory medication update with all the information, the evidence and best practice guidance to feel confident with your prescriptive decision making.


Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.

* Credit Note - **

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.

Nurses - Pharmacology Nurse Practitioners

This self-study program offers 385 instructional minutes of pharmacology content which is designed to qualify for 6.25 contact hours toward your pharmacology requirement. 

Nurses - Nurses, Nurse Practitioners, and Clinical Nurse Specialists - ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 6.25 contact hours. Expires: 09/13/2024.

Nurses - California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 6.0 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Nurses - Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 6.0 self-study contact hours.

CE Broker

Nurses - Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 6.25 self-study contact hours. Please email with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.

Physicians Assistants - Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 6.0 hours for completing this self-study program. This activity was originally recorded on 09/13/2021. It was last reviewed on 10/18/2021 and is valid until 10/18/2024


PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™.

Other Professions

This self-study activity qualifies for 6.25 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Paul Langlois, APN, PhD, CCRN, CCNS's Profile

Paul Langlois, APN, PhD, CCRN, CCNS Related seminars and products

Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.

Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.

His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.  


Speaker Disclosures:
Financial: Paul Langlois has employment relationships with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Paul Langlois is a member of the American Nurses Association and the American Association of Critical Care Nurses.

Additional Info

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Visit our FAQ page at or contact us at


  1. Differentiate the two receptors in the lungs which are responsible for airway constriction and dilation. 
  2. Analyze the medication options for patients with alpha-1 anti-trypsin deficiency. 
  3. Choose the medications which are prescribed for asthma and COPD. 
  4. Determine the medications which are used during acute asthma attack. 
  5. Evaluate the vaccines recommended for patients with pulmonary conditions. 
  6. Manage the medications which are recommended for the COVID-19 patient both out- and in-patient. 
  7. Formulate a medication regimen for a tuberculosis patient, both newly diagnosed and with drug-resistant tuberculosis. 
  8. Plan the treatment protocol for a patient with pulmonary hypertension. 
  9. Distinguish between antiviral medications for viral respiratory diseases. 
  10. Choose the best antibiotic for the in- and out-patient with bacterial pneumonia. 


Pulmonary Anatomy, Physiology & Lung Receptors
  • Pulmonary ventilation key factors
  • Improve diffusion of CO2 and O2 are dependent on a specific variable
  • Variables that affect the transport of CO2 and O2 at the cellular level
  • Muscarinic and beta-2 receptors in the lung are vital for airway dilation – but how much?
  • Club cell and columnar cell for airway patency
  • Role of the sympathetic and parasympathetic nervous system in airway disease
Alpha-1 Antitrypsin Deficiency
  • Why are levels of alpha-1 antitrypsin reduced in some people?
  • Medications to treat alpha-1 antitrypsin deficiency
  • Monitoring patient parameters after administering medications
Asthma – Not Just Bronchodilators Anymore
  • How is asthma diagnosed?
  • Role of white blood cells, histamine & the arachidonic pathway in asthma
  • Medications that affect IgE mediator release - a major contributor to asthma
  • Global Initiative for Asthma (GINA) medication options
  • Role of corticosteroids in asthma treatment
  • Short acting beta agonists (SABA) & long-acting beta agonists (LABA) - the difference and monitoring parameters
  • Muscarinic antagonists, leukotriene modifiers & phosphodiesterase inhibitors - must know indications and contraindications to treat the asthma patient
  • Monoclonal antibodies for asthma relief
Chronic Obstructive Pulmonary Disease (COPD) – Long Term Pharmacologic Therapies
  • COPD causes, symptoms and diagnostic tests
  • Non-pharmacologic treatments
  • SABA and LABA - when and how much
  • Inhaled corticosteroids alone or in combination with bronchodilators
  • Vaccines are a must – which ones and at what age to administer
SARS-CoV2, COVID-19 – what is new … A LOT!!!
  • Pathophysiology of SARS-CoV2
  • Is the virus only transmitted via air … you have to see this data?
  • Laboratory parameters for SARS-CoV2
  • How effective are all those COVID-19 vaccines?
  • Which antiviral medications are FDA approved and which are still in clinical trials?
  • Baricitinib and Tocilizumab show a lot of promise
  • So, what about Ivermectin – data on its effectiveness
  • Dexamethasone is effective, but only in certain patient populations
Cystic Fibrosis (CF)
  • Role of genetics and genetic testing in development of CF
  • CF affects more than the lungs
  • What medications are prescribed and routes of administration
  • Role of monoclonal antibodies – what you must monitor in your patient for these medications
Tuberculosis (TB): Still prevalent & Highly Contagious
  • What is Mycobacterium tuberculosis and how is it detected?
  • Geographic concerns for newly diagnosed and multi-drug resistant-TB
  • First line medications for drug susceptible TB (doses, how often & how long to take)
  • Multi-drug resistant TB treatments
Pulmonary Hypertension
  • Diagnosis of pulmonary hypertension
  • 12-lead ECG results in a patient with pulmonary hypertension
  • World Health Organization (WHO) treatment classifications
  • How to choose between calcium channel blockers, phosphodiesterase inhibitors, endothelin receptor antagonizes and prostacyclin agonists
Acute Bronchitis – Lower Respiratory Tract Infection
  • Bacterial and viral pathogens associated with acute bronchitis
  • Clinical features - from days to weeks after infection
  • Role of dextromethorphan – watch out for this side effect
  • Decide between an anti-viral or antibacterial - look for this in your patient
  • Causes and who is at risk for aspergillosis
  • Voriconazole, Posaconazole, Amphotericin B – these are the “must do” monitoring parameters
Legionnaires Disease
  • Which test should be used to diagnose Legionnaires Disease - urine, blood culture or polymerase chain reaction
  • Patient susceptibility to Legionnaires Disease
  • Ciprofloxacin, Moxifloxacin, Clarithromycin, Erythromycin, Amikacin, Levofloxacin, Azithromycin - look carefully at the indications and contraindications
Pertussis (Whooping Cough) – Still Present Despite Vaccinations
  • Three phases of pertussis
  • Medications and monitoring parameters
  • Pharmacology for cough suppression
  • Community acquired, hospital acquired & ventilator associated
  • Community acquired treatment options
  • Options for antibiotics based on patient history
  • Hospital acquired pharmacology
  • How to treat methicillin resistant staphylococcus aureus
Pneumocystis Pneumonia
  • What is the protozoan causing this?
  • Trimethoprim-sulfamethoxazole is not for everyone - renal adjustment? Pregnancy?
  • Atovaquone indications - contraindications and monitoring
  • Use of Pentamidine and Primaquine with Clindamycin – how much and how long

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants
  • Pharmacists


Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

Please wait ...

Back to Top